Peer-influenced content. Sources you trust. No registration required. This is HCN.

Hematology AdvisorReducing Hypophosphatemia Risk Associated with Parenteral Iron Repletion

This “Clinician POV” with Joshua Strauss, MD, a hematologist-oncologist with Advanced Care Hematology & Oncology Associates in New Jersey, discusses the available formulations of parenteral iron and their respective risks for hypophosphatemia, patient- and disease-related factors of the condition, administration of the formulations, monitoring, and more.